Updated: Apr 8, 2022
New drug approvals are difficult. Approval for a new analytics platform can be as difficult. Your decision can have major ramifications on your financial health.
First, review traditional pharma technologies or tools which are like expired drugs. Take, for example, tools like Pharmaceutical Distribution Management, Medical Representative Reporting, or Pharma Business management. These tools will not give you real-time visibility. You need a tool that will give you a granular view of your pharma business. Just like a CT Scan!
You may have the data, but you have stored it in multiple excel sheets across your company. You need an integrated solution to process and analyse sales, marketing, and distribution data. When it comes to making decisions about your financial health you’ve got to do it at the speed of thought.
No actionable insights to empower sales heads.
Swift responses to cut down decision-making times.
Bias in data analysis.
Absolute transparency and great operational speed.
Manual management of data.
Macro and microdata sources are integrated on a single platform.
The inability of sales teams to ‘see’ patterns and take suitable action.
A phenomenal increase in ‘sales teams’ efficiency, in ways you never before thought possible.
Inability to track sales across markets.
Ability to think strategically and deploy efficiently during ongoing sales cycles.
Unproductive face-to-face selling time.
Handle sales remotely, yet more skillfully.
Reduce inventory planning errors!
Centralize procurement function.
Track marketing spends.
Increase profitability of territories.
Track performance of channel segments.
Now, wait for a remarkable reversal of financial ‘dis-ease’.
Decision-makers can engage with KAM – Key Account Managers and IDNs – Integrated Delivery Networks and Payers.